ResearcherGerman Cancer Research CenterActive in the last 2 years

Ivana Đokić

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0003-7808-5366; OpenAlex author ID A5063847145. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy Last author DOI 10.1016/j.phro.2025.100803 ↗
Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. Co-author DOI 10.3390/cancers16081497 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Mairani · 2 shared papers, 2024–2025 · strength 0.42
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497 ↗
- Paper First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy DOI 10.1016/j.phro.2025.100803 ↗
Jürgen Debus · 2 shared papers, 2024–2025 · strength 0.42
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497 ↗
- Paper First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy DOI 10.1016/j.phro.2025.100803 ↗
Jakob Liermann · 1 shared paper, 2024 · strength 0.21
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497 ↗
Klaus K Herfarth · 1 shared paper, 2024 · strength 0.21
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497 ↗
Bahar Cepni · 1 shared paper, 2024 · strength 0.21
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497 ↗
Celine Karle · 1 shared paper, 2025 · strength 0.21
- Paper First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy DOI 10.1016/j.phro.2025.100803 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.